Abstract:Objective To explore the role of RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) pathway in the crosstalk of apoptosis and autophagy in human osteosarcoma HOS cells induced by pyropheophorbide-a methyl ester-mediated photodynamic therapy (MPPa-PDT) and investigate the mechanism by which PERK pathway inhibition enhances the sensitivity of the cells to MPPa-PDT. Methods We first observed the apoptotic morphology of human osteosarcoma HOS cells after MPPa-PDT using Hoechst 33258 staining. HOS cells were treated with MPPa-PDT alone or in combination with a PERK inhibitor (GSK2656157) or an autophagy inhibitor (Bafilomycin A1), and the changes in the expression of the proteins related to PERK pathway (PERK, p-PERK, ATF4, and CHOP), apoptosis (Cleaved caspase-3, Cleaved PARP) and autophagy (LC3-Ⅱ/LC3-Ⅰ and P62) were investigated using Western blotting; the changes in the expression of p-PERK was also examined using immunofluorescence assay. The cell apoptotic rates following the treatments were analyzed using flow cytometry. Results MPPa-PDT resulted in typical morphological changes of apoptosis (nuclear pyknosis and fragmentation) in HOS cells, and induced obvious autophagy and activation of PERK pathway. HOS cells treated with MPPa-PDT, compared with the control cells, showed significantly increased expression of Cleaved caspase-3, Cleaved PARP, LC3-Ⅱ/LC3-Ⅰ, p-PERK, ATF4 and CHOP and lowered expression of P62 and PERK; the cells exhibited stronger green fluorescence signals of p-PERK after MPPa-PDT treatment than the control cells. The application of GSK2656157 significantly blocked MPPa-PDT-induced increases in p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ expression levels, while treatment of the cells with GSK2656157 prior to MPPa-PDT enhanced the cell apoptosis and increased the expression levels of PERK, P62, Cleaved caspase-3 and Cleaved PARP. The cells with combined treatment with MPPa-PDT and GSK2656157 showed weaker green fluorescence signal of p-PERK than those with MPPa-PDT alone. Pretreatment of the cells with Bafilomycin A1 augmented the effects of MPPa-PDT to increase the expression levels of LC3-Ⅱ/LC3-Ⅰ, P62, Cleaved caspase-3 and Cleaved PARP and the apoptosis rate. Compared with the cells with combined MPPa-PDT and GSK2656157 treatment, the cells treated with MPPa-PDT and Bafilomycin A1 showed significantly increased levels of p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ and obviously lowered apoptotic rate and expression levels of PERK, Cleaved caspase-3 and Cleaved PARP. Conclusion The activation of PERK pathway induced by MPPa-PDT may mediate prosurvival autophagy and unfolded protein response, and blocking PERK pathway enhances the killing effect of MPPa-PDT in human osteosarcoma HOS cells.

Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT

Inhibition of PERK pathway enhances sensitivity of human osteosarcoma HOS cells induced to pyropheophorbide-a methyl ester-mediated photodynamic therapy

Targeting X Box-Binding Protein-1 (XBP1) Enhances the Sensitivity of HOS Osteosarcoma Cells to Pyropheophorbide- Α Methyl Ester-Mediated Photodynamic Therapy.

The Role of CTLA-4 and PD-1 in Anti-Tumor Immune Response and Their Potential Efficacy Against Osteosarcoma

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Targeting GRP78 enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy via the Wnt/β-catenin signaling pathway

PTEN loss activates a functional AKT/CXCR4 signaling axis to potentiate tumor growth and lung metastasis in human osteosarcoma cells

Synergistic induction of ferroptosis by targeting HERC1-NCOA4 axis to enhance the photodynamic sensitivity of osteosarcoma

Chondroitin Polymerizing Factor (CHPF) Promotes Cell Proliferation and Tumor Growth in Human Osteosarcoma by Inhibiting SKP2's Ubiquitination While Activating the AKT Pathway

RhoA Enhances Osteosarcoma Resistance to MPPa-PDT Via the Hippo/YAP Signaling Pathway

Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications

A multifunctional biomimetic nanoplatform for image-guideded photothermal-ferroptotic synergistic osteosarcoma therapy

New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis

HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling

PF-06409577 Activates AMPK Signaling and Inhibits Osteosarcoma Cell Growth

Biomimetic Targeted Co‐Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma

Antitumor Effects and Mechanisms of Pyropheophorbide‑α Methyl Ester‑mediated Photodynamic Therapy Onthe Human Osteosarcoma Cell Line MG‑63

Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma.

Intratibial osteosarcoma growth and pulmonary metastasis inhibition by HIPPO signaling pathway-induced photodynamic therapy

PI3K/Akt signaling in osteosarcoma

Mitochondria targeted biomimetic platform for chemo/photodynamic combination therapy against osteosarcoma